CHARLES ROGERS: Open Payments
NPI 1528504644 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 29 payments from 9 companies in 2025. Trend: 2023 $266 · 2024 $237 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $165 |
| Novo Nordisk Inc | 6 | $141 |
| Corcept Therapeutics | 3 | $61 |
| Lilly USA, LLC | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, Rybelsus, Korlym, Wegovy, MOUNJARO, HETLIOZ, CAPLYTA, Ozempic.
Industry payments across KY — which companies pay providers there.
